Cyclacel Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
16.25
|
|
Average Rating
|
4.75
|
|
# Strong Buys
|
3
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.56
|
-0.42
|
0.14
|
25.00%
|
|
2022-06-30
|
-0.62
|
-0.46
|
0.16
|
25.81%
|
|
2022-03-31
|
-0.68
|
-0.42
|
0.26
|
38.24%
|
|
2021-12-31
|
-0.65
|
-0.54
|
0.11
|
16.92%
|
|
2021-09-30
|
-0.65
|
-0.54
|
0.11
|
16.92%
|
|
2021-06-30
|
-0.50
|
-0.56
|
-0.06
|
-12.00%
|
|
2021-03-31
|
-0.49
|
-0.50
|
-0.01
|
-2.04%
|
|
2020-12-31
|
-0.51
|
-1.34
|
-0.83
|
-162.75%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.30
|
|
2021-12-31
|
-2.14
|
|
2020-12-31
|
-3.87
|
|
2019-12-31
|
-10.00
|
|
2018-12-31
|
-12.60
|
|
2017-12-31
|
-22.28
|
|
2016-12-31
|
-42.50
|
|
2015-12-31
|
-28.15
|
|
2014-12-31
|
-117.96
|
|
2013-12-31
|
-382.02
|
|
2012-12-31
|
-403.75
|
|
2011-12-31
|
-537.60
|
|
2010-12-31
|
-907.20
|
|
2009-12-31
|
-1512.00
|
|
2008-12-31
|
-3326.40
|
|
2007-12-31
|
-2049.60
|
|
2006-12-31
|
-5023.20
|
|
2005-12-31
|
-25032.00
|
|
2004-12-31
|
-50064.00
|